BIT
GNMK

BlackRock Institutional Trust’s GenMark Diagnostics, Inc GNMK Stock Holding History

BlackRock Institutional Trust’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$14.4M Buy
1,179,391
+305,150
+35% +$3.62M ﹤0.01% 2181
2016
Q3 		$10.3M Buy
874,241
+156,965
+22% +$1.52M ﹤0.01% 2316
2016
Q2 		$6.24M Sell
717,276
-13,647
-2% -$93.6K ﹤0.01% 2562
2016
Q1 		$3.85M Sell
730,923
-4,110
-0.6% -$22.9K ﹤0.01% 2777
2015
Q4 		$5.7M Buy
735,033
+19,478
+3% +$150K ﹤0.01% 2643
2015
Q3 		$5.63M Buy
715,555
+73,923
+12% +$684K ﹤0.01% 2652
2015
Q2 		$5.81M Buy
641,632
+10,794
+2% +$109K ﹤0.01% 2707
2015
Q1 		$8.19M Buy
630,838
+119,137
+23% +$1.56M ﹤0.01% 2516
2014
Q4 		$6.96M Buy
511,701
+54,404
+12% +$608K ﹤0.01% 2564
2014
Q3 		$4.1M Sell
457,297
-37,318
-8% -$402K ﹤0.01% 2783
2014
Q2 		$6.69M Buy
494,615
+81,256
+20% +$848K ﹤0.01% 2637
2014
Q1 		$4.11M Buy
413,359
+3,328
+0.8% +$41.4K ﹤0.01% 2856
2013
Q4 		$5.45M Sell
410,031
-24,407
-6% -$296K ﹤0.01% 2740
2013
Q3 		$5.27M Buy
434,438
+118,529
+38% +$1.27M ﹤0.01% 2704
2013
Q2 		$3.27M Buy
+315,909
New +$4.36M ﹤0.01% 2880

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Institutional Trust's GNMK Position: Q4 2016 in Review

BlackRock Institutional Trust increased its GenMark Diagnostics, Inc (GNMK) stake by 35% in Q4 2016, buying an estimated $3.62M and bringing the position to 1,179,391 shares worth $14.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2181.

BlackRock Institutional Trust first reported a position in GNMK in Q2 2013 and has held it in 15 quarters since. 90 funds tracked by Wall St. Rank hold GNMK as of Q4 2016.

  • BlackRock Institutional Trust held 1,179,391 shares of GenMark Diagnostics, Inc worth $14.4M as of Q4 2016.
  • BlackRock Institutional Trust bought 305,150 GenMark Diagnostics, Inc shares in Q4 2016, an estimated $3.62M.
  • GenMark Diagnostics, Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2181 holding.
  • BlackRock Institutional Trust first reported a position in GenMark Diagnostics, Inc in Q2 2013 and has held it in 15 quarters since.
  • 90 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.